AUDREY MATTESON: Open Payments
NPI 1871238378 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 16 payments from 11 companies in 2025. Trend: 2023 $35 · 2024 $0 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| ABBVIE INC. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Exact Sciences Corporation | 1 | $24 |
| Boston Scientific Corporation | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Corcept Therapeutics | 1 | $16 |
Products named: CAPLYTA, QULIPTA, FARXIGA, AIRSUPRA, Cologuard Collection Kit, VRAYLAR, General - Embolics, REXULTI.
Industry payments across OH — which companies pay providers there.
